Day One Biopharmaceuticals Stock Technical Analysis
| DAWN Stock | USD 12.65 0.04 0.32% |
As of the 24th of December, Day One shows the Variance of 5.14, mean deviation of 1.84, and Standard Deviation of 2.27. Day One Biopharmaceu technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Day One Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Day, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to DayDay |
Day One Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 38.78 | Strong Buy | 10 | Odds |
Most Day analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Day stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Day One Biopharmaceu, talking to its executives and customers, or listening to Day conference calls.
Day One technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Day One Biopharmaceu Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Day One Biopharmaceu volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Day One Biopharmaceu Trend Analysis
Use this graph to draw trend lines for Day One Biopharmaceuticals. You can use it to identify possible trend reversals for Day One as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Day One price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Day One Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Day One Biopharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that Day One Biopharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 28.63, which is the sum of squared deviations for the predicted Day One price change compared to its average price change.About Day One Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Day One Biopharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Day One Biopharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Day One Biopharmaceu price pattern first instead of the macroeconomic environment surrounding Day One Biopharmaceu. By analyzing Day One's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Day One's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Day One specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 33.43 | 20.94 | 12.72 | 22.7 | Net Debt To EBITDA | 3.92 | 0.6 | 1.12 | 1.83 |
Day One December 24, 2024 Technical Indicators
Most technical analysis of Day help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Day from various momentum indicators to cycle indicators. When you analyze Day charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 1.84 | |||
| Coefficient Of Variation | (1,105) | |||
| Standard Deviation | 2.27 | |||
| Variance | 5.14 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 11.05 | |||
| Value At Risk | (3.69) | |||
| Potential Upside | 3.03 | |||
| Skewness | (0.40) | |||
| Kurtosis | 0.1085 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Revenue Per Share 1.144 | Return On Assets (0.25) | Return On Equity (0.18) |
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.